These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 23987460)
21. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties. He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877 [TBL] [Abstract][Full Text] [Related]
22. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells. He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067 [TBL] [Abstract][Full Text] [Related]
23. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery. Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851 [TBL] [Abstract][Full Text] [Related]
24. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors. Han L; Huang R; Liu S; Huang S; Jiang C Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964 [TBL] [Abstract][Full Text] [Related]
25. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug. Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849 [TBL] [Abstract][Full Text] [Related]
26. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release. Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661 [TBL] [Abstract][Full Text] [Related]
27. Uptake of oleoyl-chitosan nanoparticles by A549 cells. Zhang J; Chen XG; Peng WB; Liu CS Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414 [TBL] [Abstract][Full Text] [Related]
28. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation. Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170 [TBL] [Abstract][Full Text] [Related]
29. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers. Raja MA; Katas H; Jing Wen T PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222 [TBL] [Abstract][Full Text] [Related]
30. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs. Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304 [TBL] [Abstract][Full Text] [Related]
31. Highly lipophilic pluronics-conjugated polyamidoamine dendrimer nanocarriers as potential delivery system for hydrophobic drugs. Nguyen TTC; Nguyen CK; Nguyen TH; Tran NQ Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):992-999. PubMed ID: 27772731 [TBL] [Abstract][Full Text] [Related]
32. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect. Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925 [TBL] [Abstract][Full Text] [Related]
33. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388 [TBL] [Abstract][Full Text] [Related]
34. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946 [TBL] [Abstract][Full Text] [Related]
36. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276 [TBL] [Abstract][Full Text] [Related]
37. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity. Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312 [TBL] [Abstract][Full Text] [Related]
38. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery. Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423 [TBL] [Abstract][Full Text] [Related]
39. In situ and in silico evaluation of amine- and folate-terminated dendrimers as nanocarriers of anesthetics. Carrasco-Sánchez V; Vergara-Jaque A; Zuñiga M; Comer J; John A; Nachtigall FM; Valdes O; Duran-Lara EF; Sandoval C; Santos LS Eur J Med Chem; 2014 Feb; 73():250-7. PubMed ID: 24412500 [TBL] [Abstract][Full Text] [Related]
40. Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications. Navath RS; Menjoge AR; Wang B; Romero R; Kannan S; Kannan RM Biomacromolecules; 2010 Jun; 11(6):1544-63. PubMed ID: 20415504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]